The ROE as of December 2025 (TTM) for Middle East Pharmaceutical Industries Company (4016.SR) is 25.73%

According to Middle East Pharmaceutical Industries Company’s latest financial reports and current stock price. The company's current ROE is 25.73%. This represents a change of 298.29% compared to the average of 6.46% of the last 4 quarters.

Middle East Pharmaceutical Industries Company (4016.SR) Historical ROE (quarterly & annually)

How has 4016.SR ROE performed in the past?

The mean historical ROE of Middle East Pharmaceutical Industries Company over the last ten years is 23.82%. The current 25.73% ROE has changed 8.04% with respect to the historical average. Over the past ten years (40 quarters), 4016.SR's ROE was at its highest in in the December 2024 quarter at 12.17%. The ROE was at its lowest in in the March 2023 quarter at -0.18%.

Middle East Pharmaceutical Industries Company (4016.SR) ROE by Quarter and Year

Discovering the peaks and valleys of Middle East Pharmaceutical Industries Company ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Middle East Pharmaceutical Industries Company (4016.SR) Average ROE

How has 4016.SR ROE performed in the past?

The current ROE of Middle East Pharmaceutical Industries Company (4016.SR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Middle East Pharmaceutical Industries Company (4016.SR) ROE vs. Peers

How is 4016.SR’s ROE compared to its peers?

Middle East Pharmaceutical Industries Company’s ROE is less than Saudi Pharmaceutical Industries and Medical Appliances Corporation (7.94%), less than Almujtama Alraida Medical Co. (7.28%), less than Scientific and Medical Equipment House Company (5.33%), less than Al-Dawaa Medical Services Company (25.13%), less than Naba Alsaha Medical Services Company (11.18%), less than Ame Company For Medical Supplies (31.13%), less than Middle East Healthcare Company (21.04%), less than Canadian General Medical Center Complex Company (8.07%), less than Qomel Co. (19.11%), less than Al-Modawat Specialized Medical Co. (16.16%),

Build a custom stock screener for Middle East Pharmaceutical Industries Company (4016.SR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Middle East Pharmaceutical Industries Company using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Middle East Pharmaceutical Industries Company (4016.SR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Middle East Pharmaceutical Industries Company or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.